About StemoniX
StemoniX is a company based in San Diego (United States) founded in 2014 was acquired by Cancer Genetics in August 2020.. StemoniX has raised $33.7 million across 11 funding rounds from investors including Cancer Genetics, Brightstone Venture Capital and Seed San Diego. StemoniX operates in a competitive market with competitors including Slingshot Bioscience, InterAx Biotech, ZoBio, Magnitude Biosciences and Signal Pharmaceuticals, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$33.7 M (USD)
in 11 rounds
-
Latest Funding Round
$100 K (USD), Series B
May 15, 2020
-
Investors
Cancer Genetics
& 10 more
-
Employee Count
Employee Count
-
Acquired by
Cancer Genetics
(Aug 24, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of StemoniX
StemoniX has successfully raised a total of $33.7M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $100 thousand completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series B — $100,000
- First Round First Round
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Series B - StemoniX | Valuation |
investors |
|
| Oct, 2019 | Amount | Series B - StemoniX | Valuation |
investors |
|
| Feb, 2019 | Amount | Series B - StemoniX | Valuation | Brightstone Venture Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in StemoniX
StemoniX has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Cancer Genetics, Brightstone Venture Capital and Seed San Diego. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
VC firm investing in early-stage mediatech & technology startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by StemoniX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - StemoniX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Stemonix Comparisons
Competitors of StemoniX
StemoniX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Slingshot Bioscience, InterAx Biotech, ZoBio, Magnitude Biosciences and Signal Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Next-generation synthetic cells are developed for diagnostics and therapeutics.
|
|
| domain | founded_year | HQ Location |
Mutated arrestins are employed as biosensors for GPCR drug discovery.
|
|
| domain | founded_year | HQ Location |
Provider of fragment-based drug discovery services
|
|
| domain | founded_year | HQ Location |
Cell-free in vitro assays are supplied to drug discovery firms.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs regulating disease-associated genes are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Stemonix
Frequently Asked Questions about StemoniX
When was StemoniX founded?
StemoniX was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is StemoniX located?
StemoniX is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of StemoniX?
Ping Yeh is the current CEO of StemoniX.
Is StemoniX a funded company?
StemoniX is a funded company, having raised a total of $33.7M across 11 funding rounds to date. The company's 1st funding round was a Series B of $14.4M, raised on May 04, 2015.
What does StemoniX do?
StemoniX is a regenerative medicine company engages in the production, growth, and development of stem cell and stem cell technologies. Makes plates of human tissue for custom drug discovery that is enabled by a rapid, low cost high volume process for growing and differentiating stem cells. Technology developed by company will allow pharma companies and drug researchers to test their drug efficacy, toxicity before lengthy clinical trials.
Who are the top competitors of StemoniX?
StemoniX's top competitors include Magnitude Biosciences, Slingshot Bioscience and Sequence Bio.
Who are StemoniX's investors?
StemoniX has 11 investors. Key investors include Cancer Genetics, Brightstone Venture Capital, Seed San Diego, Keshif Ventures, and Mayo Clinic Business Accelerator.